Background Incomplete adherence to tuberculosis (TB) treatment increases the risk of
delayed culture conversion with continued transmission in the community, as well as …

BACKGROUND: Despite effective anti-tuberculosis chemotherapy, case-fatality rates of up
to 25% are described in both industrialised and resource-poor settings. An understanding of …

The WHO Consolidated Guidelines on Tuberculosis (TB), Module 4: Treatment-Drug-
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …

Executive summary Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult
to treat than drug-susceptible ones, and threaten global progress towards the targets set by …

In order to support countries in their effort to respond to the challenges posed by the TB
epidemic over the years, WHO has produced and regularly updated guidelines for the …

Tuberculosis disproportionately affects hard-to-reach populations, such as homeless
people, migrants, refugees, prisoners, or drug users. These people often face challenges in …

Background The development of drug-resistant (DR) tuberculosis (TB) has become an
increasing concern over the past few decades as the result of numerous factors, including …

Background Asthma, a worldwide health problem, can be controlled if properly diagnosed
and managed. Multinational surveys conducted in patients with asthma from 1998 to 2003 …

Background Recently, the tuberculosis (TB) Task Force Impact Measurement acknowledged
the need to review the assumptions underlying the TB mortality estimates published …

In low-incidence countries in the European Union (EU), tuberculosis (TB) is concentrated in
big cities, especially among certain urban high-risk groups including immigrants from TB …